One-Pot Synthesis of Isoindolin-1-ones with Thiamine Hydrochloride (VB₁) as a Catalyst and Their Inhibitory Activity Against Cancer Cell Lines

References

• Zhang, S. H., C. Y. Wang, Z. Z., Jiang, P. Z. Ni, J. P. Zhou, B. M. Xi, and W. H. Chen. “Synthesis and Blocking Activities of Isoindolinone- and Isobenzofuranone-Containing Phenoxylalkylamines as Potent α(1)-Adrenoceptor Antagonists.” Chem. Pharm. Bull. 59 (2011): 96–9.
   PubMed Web of Science ®Google Scholar
• Norman, M. H., D. J. Minick, and G. C. Rigdon. “Effect of Linking Bridge Modifications on the Antipsychotic Profile of Some Phthalimide and Isoindolinonederivatives.” J. Med. Chem. 39 (1996): 149–57.
   PubMed Web of Science ®Google Scholar
• Watson A. F., J. Liu, K. Bennaceur, C. J. Drummond, J. A. Endicott, B. T. Golding, R. J. Griffin, K. Haggerty, X. Lu, J. M. McDonnell, D. R. Newell, M. E. Noble, C. H. Revill, G. Riedinger, Q. Xu, Y. Zhao, J. Lunec, and I. R. Hardcastle. “MDM2-p53 Protein-protein Interaction Inhibitors: A-Ring Substituted Isoindolinones.” Bioorg. Med. Chem. Lett. 21 (2011): 5916–9.
   PubMed Web of Science ®Google Scholar
• Hardcastle, I. R., S. Ahmed, H. Atkins, G. Farnie, B. Golding, R. Griffin, S. Guyenne, C. Hutton, P. Källblad, S. Kemp, M. Kitching, D. Newell, S. Norbedo, J. Northen, R. Reid, K. Saravanan, H. Willems, and J. Lunec. “Small-molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction Based on an Isoindolinone Scaffold.” J. Med. Chem. 49 (2006): 6209–21.
   PubMed Web of Science ®Google Scholar
• Hardcastle I. R., J. Liu, E. Valeur, A. Watson, S. Ahmed, T. Blackburn, K. Bennaceur, W. Clegg, C. Drummond, J. Endicott, B. Golding, R. Griffin, J. Gruber, K. Haggerty, R. Harrington, C. Hutton, S. Kemp, X. Lu, J. McDonnell, D. Newell, M. Noble, S. Payne, C. Revill, C. Riedinger, Q. Xu, and J. Lunec. “Isoindolinone Inhibitors of the Murine Double Minute 2 (MDM2)-p53 Protein-Protein Interaction: Structure-Activity Studies Leading to Improved Potency.” J. Med. Chem. 54 (2011): 1233–43.
   PubMedGoogle Scholar
• Curtin M. L., R. Frey, H. Heyman, K. Sarris, D. Steinman, J. Holmes, P. Bousquet, G. Cunha, M. Moskey, A. Ahmed, L. Pease, K. Glaser, K. Stewart, S. Davidsen, and M. Michaelides. “Isoindolinone Ureas: A Novel Class of KDR Kinase Inhibitors.” Bioorg. Med. Chem. Lett. 14 (2014): 4505–9.
   PubMed Web of Science ®Google Scholar
• Lawson E. C., D. Luci, S. Ghosh, W. Kinney, C. Reynolds, J. Qi, C. Smith, Y. Wang, L. Minor, B. Haertlein, T. Parry, B. Damiano, and B. Maryanoff. “Nonpeptide Urotensin-II Receptor Antagonists: A New Ligand Class Based on Piperazino-Phthalimide and Piperazino-Isoindolinone Subunits.” J. Med. Chem. 52 (2009): 7432–45.
   PubMed Web of Science ®Google Scholar
• Nitya G. K., K. Waha, and S. Jyan. “Palladium-catalysed Heteroannulation with Acetylenic Carbinols: Synthesis of 3-Acylmethylisoindolin-1-ones.” J. Chem. Res. (1999): 460–1.
   Google Scholar
• Wu F. L., W. Zhang, and C. Wang. Synthesis of Benzopyrrolizidinones by Norrish–Yang Cyclization of 3-(Acylmethyl)-2-alkylisoindol-1-ones.” Synthesis 11 (2009): 1821–8.
   Google Scholar
• Devineau A., G. Pousse, C. Taillier, J. Blanchet, and V. Dalla. One-Pot Hydroxy Group Activation/Carbon-Carbon Bond Forming Sequence using a Brønsted Base/Brønsted Acid System.” Adv. Syn. Catal. 352 (2010): 2881–6.
   Web of Science ®Google Scholar
• Lei, M., L. Ma, and L. Hu. “Thiamine Hydrochloride-Catalyzed One-Pot Synthesis of 1,4-Dihydropyridine Derivatives under Solvent-Free Conditions.” Syn. Commun. 41 (2011): 1969–76.
   Web of Science ®Google Scholar
• Lei, M., L. Ma, and L. Hu. “Highly Chemoselective Condensation of β-Naphthol, Aldehyde, and Urea Catalyzed by Thiamine Hydrochloride.” Syn. Commun. 41 (2011): 3424–32.
   Web of Science ®Google Scholar
• Chen, Y. J., W. Shan, M. Lei, and L. Hu. “Thiamine Hydrochloride (VB1) as an Efficient Promoter for the One-pot Synthesis of 2,3-Dihydroquinazolin-4(1H)-ones.” Tetrahedron Lett. 53 (2012): 5923–5.
   Google Scholar
• Hu, L., D. Guo, Z. Xiao, X. Liu, B. Ma, and M. Lei. “Bufogenin derivative and preparation method, composition containing bufogenin derivative and applications.” King Sound & Partners, Inc., assignee. Chinese patent CN 102532235B (2012).
   Google Scholar